|
NL154598B
(nl)
*
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
*
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
*
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3901855A
(en)
|
1974-08-07 |
1975-08-26 |
Us Air Force |
Preparation of polybenzimidazoles
|
|
US3996345A
(en)
*
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
*
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4227437A
(en)
|
1977-10-11 |
1980-10-14 |
Inloes Thomas L |
Frequency detecting apparatus
|
|
US4277437A
(en)
*
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
*
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4403607A
(en)
*
|
1980-05-09 |
1983-09-13 |
The Regents Of The University Of California |
Compatible internal bone fixation plate
|
|
US4366241A
(en)
*
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
JPS61113060A
(ja)
|
1984-11-08 |
1986-05-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
US5120643A
(en)
*
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
DE3825041A1
(de)
|
1988-07-20 |
1990-02-15 |
Schering Ag |
Pyrido(3,2-e)(1,2,4)triazolo(1,5-a)pyrimidin- 2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwachstumsregulierender und fungizider wirkung
|
|
JPH04364168A
(ja)
|
1990-08-08 |
1992-12-16 |
Taisho Pharmaceut Co Ltd |
スルホンアミドピリジン化合物
|
|
ATE167473T1
(de)
*
|
1990-08-20 |
1998-07-15 |
Eisai Co Ltd |
Sulfonamid-derivate
|
|
JPH06135934A
(ja)
|
1991-12-27 |
1994-05-17 |
Ishihara Sangyo Kaisha Ltd |
ピリジン誘導体又はその塩を含有するホスホリパーゼ▲ａ２▼阻害剤、抗炎症剤又は抗膵炎剤
|
|
JPH06145145A
(ja)
|
1991-12-27 |
1994-05-24 |
Ishihara Sangyo Kaisha Ltd |
アミノトリフルオロメチルピリジン誘導体又はその塩、それらの製造方法及びそれらを含有するホスホリパーゼａ▲２▼阻害剤、抗炎症剤並びに抗膵炎剤
|
|
US6159686A
(en)
*
|
1992-09-14 |
2000-12-12 |
Sri International |
Up-converting reporters for biological and other assays
|
|
US5514555A
(en)
|
1993-03-12 |
1996-05-07 |
Center For Blood Research, Inc. |
Assays and therapeutic methods based on lymphocyte chemoattractants
|
|
US5571775A
(en)
*
|
1994-07-11 |
1996-11-05 |
Dowelanco |
N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
|
|
EP1334719A3
(en)
|
1996-02-22 |
2003-09-24 |
Tularik, Inc. |
Pentafluorobenzenesulfonamides and analogs
|
|
US5780488A
(en)
*
|
1996-04-03 |
1998-07-14 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
ATE360689T1
(de)
|
1996-09-10 |
2007-05-15 |
Kocher Theodor Inst |
Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
|
|
AR015104A1
(es)
*
|
1996-11-13 |
2001-04-18 |
Dowelanco |
Compuestos de n-arilsulfilimina sustituidos, utiles como catalizadores en la preparacion de compuestos de n-arilarilsulfonamida; proceso para preparar dichos compuestos y su uso para catalizar dicha preparacion.
|
|
US6322901B1
(en)
*
|
1997-11-13 |
2001-11-27 |
Massachusetts Institute Of Technology |
Highly luminescent color-selective nano-crystalline materials
|
|
US5990479A
(en)
*
|
1997-11-25 |
1999-11-23 |
Regents Of The University Of California |
Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
|
US6207392B1
(en)
*
|
1997-11-25 |
2001-03-27 |
The Regents Of The University Of California |
Semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
|
GB9803228D0
(en)
*
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
|
EP0937711A1
(de)
|
1998-02-18 |
1999-08-25 |
Roche Diagnostics GmbH |
Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
JP4327915B2
(ja)
*
|
1998-03-30 |
2009-09-09 |
株式会社デ・ウエスタン・セラピテクス研究所 |
スルフォンアミド誘導体
|
|
US6306610B1
(en)
*
|
1998-09-18 |
2001-10-23 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
US6251303B1
(en)
*
|
1998-09-18 |
2001-06-26 |
Massachusetts Institute Of Technology |
Water-soluble fluorescent nanocrystals
|
|
US6326144B1
(en)
*
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
US6380206B1
(en)
*
|
1998-11-23 |
2002-04-30 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives
|
|
JP2000159665A
(ja)
|
1998-11-27 |
2000-06-13 |
Nippon Kayaku Co Ltd |
リウマチの予防または治療剤
|
|
AUPP796798A0
(en)
|
1998-12-30 |
1999-01-28 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
TR200103804T2
(tr)
|
1999-06-28 |
2002-05-21 |
Janssen Pharmaceutica N.V. |
Solunum sistemi sinsitiyal virüsünün replikasyonunu inhibe edici maddeler
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
JP2001089412A
(ja)
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
|
WO2001060369A1
(en)
*
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
JP2001335714A
(ja)
|
2000-03-22 |
2001-12-04 |
Fuji Photo Film Co Ltd |
アゾ色素、その製造方法、インクジェット用インク、インクジェット記録方法
|
|
US6525051B2
(en)
|
2000-03-27 |
2003-02-25 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
WO2002000647A1
(en)
*
|
2000-06-23 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
JP3699910B2
(ja)
*
|
2000-10-31 |
2005-09-28 |
株式会社東芝 |
データ伝送装置、データ伝送方法及びプログラム
|
|
US7468253B2
(en)
|
2001-06-07 |
2008-12-23 |
Chemocentryx, Inc. |
Method for multiple chemokine receptor screening for antagonists using RAM assay
|
|
ATE347695T1
(de)
|
2001-06-07 |
2006-12-15 |
Chemocentryx Inc |
Zellwanderungsassay
|
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
JP2005516936A
(ja)
|
2001-12-18 |
2005-06-09 |
アストラゼネカ・アクチエボラーグ |
Ｎ−ピラジニル−チエニルスルホンアミドおよびケモカイン媒介疾患の治療におけるそれらの使用
|
|
US7119112B2
(en)
|
2002-02-28 |
2006-10-10 |
Icagen, Inc. |
Sulfonamides as potassium channel blockers
|
|
AU2003220401A1
(en)
|
2002-03-18 |
2003-10-08 |
Bristol-Myers Squibb Company |
Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
|
|
WO2003099773A1
(en)
|
2002-05-24 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
|
WO2003099733A1
(de)
|
2002-05-28 |
2003-12-04 |
Schott Ag |
Verfahren und vorrichtung zum blankpressen von glaskörpern
|
|
US20070021466A1
(en)
*
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
CN101077867B
(zh)
|
2002-11-18 |
2012-10-10 |
坎莫森特里克斯公司 |
芳基磺酰胺
|
|
US20060111351A1
(en)
|
2002-11-18 |
2006-05-25 |
Solomon Ungashe |
Aryl sulfonamides
|
|
CA2510471A1
(en)
|
2002-12-19 |
2004-07-08 |
Neurogen Corporation |
Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
|
|
EP1585511B1
(en)
|
2002-12-20 |
2013-01-23 |
Amgen Inc. |
Asthma and allergic inflammation modulators
|
|
AU2003290346A1
(en)
|
2002-12-24 |
2004-07-22 |
Biofocus Plc |
Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
|
|
WO2004099127A1
(en)
|
2003-05-07 |
2004-11-18 |
Novo Nordisk A/S |
Novel compounds as kinase inhibitors
|
|
JP2007500240A
(ja)
|
2003-05-29 |
2007-01-11 |
アボット・ラボラトリーズ |
Ａｂｔ−７５１による持続投与レジメン
|
|
EP1643960A2
(en)
|
2003-07-02 |
2006-04-12 |
Merck & Co., Inc. |
Arylsulfonamide derivatives
|
|
GB0322016D0
(en)
|
2003-09-19 |
2003-10-22 |
Merck Sharp & Dohme |
New compounds
|
|
EP2354126B1
(en)
*
|
2005-01-14 |
2013-09-25 |
ChemoCentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
WO2007014054A2
(en)
|
2005-07-22 |
2007-02-01 |
Glaxo Group Limted |
Benzenesulfonamide inhibitor of ccr2 chemokine receptor
|
|
WO2007014008A2
(en)
|
2005-07-22 |
2007-02-01 |
Glaxo Group Limted |
Benzenesulfonamide inhibitor of ccr2 chemokine receptor
|
|
WO2008008394A1
(en)
|
2006-07-12 |
2008-01-17 |
Transform Pharmaceuticals, Inc. |
Tizanidine succinate salt forms and methods of making and using the same
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
US20100234364A1
(en)
|
2006-07-14 |
2010-09-16 |
Arindrajit Basak |
Ccr2 inhibitors and methods of use thereof
|
|
BRPI0813695B8
(pt)
*
|
2007-07-12 |
2021-05-25 |
Chemocentryx Inc |
compostos de heteroaril piridil e fenil benzenossulfonamidas fundidas, composição, método de modular a função de ccr2, usos dos compostos e forma cristalina
|
|
US9715915B2
(en)
|
2014-10-30 |
2017-07-25 |
Samsung Electronics Co., Ltd. |
Magneto-resistive devices including a free layer having different magnetic properties during operations
|
|
US10251888B2
(en)
*
|
2016-06-13 |
2019-04-09 |
Chemocentryx, Inc. |
Method of treating pancreatic cancer
|